Mortality in various types of osteogenesis imperfecta
- PMID: 11558400
Mortality in various types of osteogenesis imperfecta
Abstract
Background: Osteogenesis imperfecta (OI) is a group of closely related inherited diseases characterized by abnormal bone fragility. The current clinical classification system delineates 6 types, one of which (type II) is so severe that mortality is 100%, either intrauterine or perinatal. The types are differentiated by clinical groups, by severity, and by the presence or absence of other features such as blue sclerae or dentinogenesis imperfecta. There are no known previous studies of mortality in OI.
Results: From a registry created in association with the Brittle Bone Society, 743 patients with OI in England and Wales were observed in the period 1980-1993. These were classified into 3 groups (type IA, type III, and types IB, IVA, and IVB combined). Average annual mortality rates were determined in each group by sex and attained age. These rates were compared with 1981 rates in the population of England and Wales, matched by sex and age. Results are given in terms of exposures, observed and expected deaths, and 2 indices of excess mortality: mortality ratios and excess death rates per 1000 person-years.
Conclusion: In type IA, 51.5% of the OI cases overall, there was no significant excess mortality (mortality ratio 108%, based on 15 deaths). In type III, on the other hand, excess mortality was very high in children and still significantly high at ages 15-34 years. In the combined group of types IB, IVA, and IVB, the mortality ratio was 157% in patients aged 45 and up (not significant at the 95% confidence level), but higher ratios at younger ages were significant, even though based on a total of only 5 deaths.
Similar articles
-
[Osteogenesis imperfecta: contribution to pathobiochemistry].Padiatr Padol. 1984;19(4):365-70. Padiatr Padol. 1984. PMID: 6504544 German.
-
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.Bone. 2007 Mar;40(3):638-44. doi: 10.1016/j.bone.2006.10.010. Epub 2006 Nov 28. Bone. 2007. PMID: 17127117 Clinical Trial.
-
A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.Clin Chim Acta. 2008 Dec;398(1-2):148-51. doi: 10.1016/j.cca.2008.07.030. Epub 2008 Aug 5. Clin Chim Acta. 2008. PMID: 18755172
-
Long-term survival after repair of tetralogy of Fallot.J Insur Med. 2000;32(2):89-92. J Insur Med. 2000. PMID: 15912907 Review.
-
Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.J Insur Med. 2002;34(1):43-60. J Insur Med. 2002. PMID: 15303593 Review.
Cited by
-
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.Orphanet J Rare Dis. 2023 Feb 22;18(1):34. doi: 10.1186/s13023-023-02627-3. Orphanet J Rare Dis. 2023. PMID: 36814274 Free PMC article. Review.
-
Lung and chest wall volume during vital capacity manoeuvre in Osteogenesis Imperfecta.Orphanet J Rare Dis. 2022 Oct 28;17(1):397. doi: 10.1186/s13023-022-02535-y. Orphanet J Rare Dis. 2022. PMID: 36307878 Free PMC article.
-
Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period.Paediatr Neonatal Pain. 2021 Dec 4;3(4):156-162. doi: 10.1002/pne2.12066. eCollection 2021 Dec. Paediatr Neonatal Pain. 2021. PMID: 35548555 Free PMC article. Review.
-
Prevalence and Hospital Admissions in Patients With Osteogenesis Imperfecta in The Netherlands: A Nationwide Registry Study.Front Endocrinol (Lausanne). 2022 Apr 25;13:869604. doi: 10.3389/fendo.2022.869604. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35546999 Free PMC article.
-
Osteogenesis Imperfecta Type 3 in a 10-Year-Old Child With Acute Respiratory Distress Syndrome.Cureus. 2022 Feb 14;14(2):e22198. doi: 10.7759/cureus.22198. eCollection 2022 Feb. Cureus. 2022. PMID: 35308738 Free PMC article.
MeSH terms
LinkOut - more resources
Medical